Introduction

▼
Gestational diabetes mellitus (GDM) is defi ned as 'carbohydrate intolerance resulting in hyperglycemia of variable severity with onset or fi rst recognition during pregnancy' [ 1 ] . GDM may aff ect up to approximately 10 % of all pregnancies, the specifi c incidence depending on the testing paradigm of diagnosis and demographics of the population being examined [ 2 ] . Up to 70 % of women with GDM go on to develop Type 2 diabetes mellitus (T2DM) over a period from 6 weeks to 28 years postpartum, with an especially rapid increase in incidence in the fi rst 5 years [ 3 ] . In addition, maternal complications of GDM include an increased risk of developing metabolic syndrome and cardiovascular disease [ 4 ] . Newborns of pregnancies aff ected by GDM are at risk of macrosomia, shoulder dystocia, birth injuries and hypoglycaemia [ 4 ] . Subclinical infl ammation is a recently discovered phenomenon in type 2 diabetes, metabolic syndrome and atherosclerosis. association between NLR and development of GDM. The aim of the present study was to investigate the predictive value of NLR on development of GDM. Exclusion criteria were as follows: (1) previously known diagnosis of diabetes mellitus; (2) the presence of an additional cardiovascular risk factor such as hypertension, hyperlipidemia or coronary artery disease; (3) presence of other factors that may aff ect ratio of WBC subset and infl ammation (corticosteroids, acetylsalicylic acid, smoking, impaired liver and kidney functions, history of trauma, any evidence of active infection, peritonitis, pancreatitis, pelvic infl ammatory disease, cancer, leukocytosis ( > 12 000/microL), leucopenia ( < 3 500/microL ), and fever.); (4) presence of an underlying chronic infl ammatory condition such as collagen tissue and infl ammatory bowel diseases.
Material and Methods
▼
The following data were extracted from the hospital database: Demographic characteristics, obstetric history, medications, history of recent infections, smoking status, alcohol consumption, and family history. Information on other risk factors for GDM such as age, pre-gestational body mass index (BMI = kg/m²), history of GDM during previous pregnancies, history of macrosomic birth and history of T2DM among fi rst-degree relatives were also documented. Following a 12-h fast, 100 g OGTT was performed for each patient starting at 8 a.m. Blood samples were taken from the ante-cubital vein in a sitting position at baseline and again on the 1 st , 2 nd and 3 rd h following 100 g glucose loading. Plasma glucose levels were measured using the glucose oxidase method (Roche Diagnostics, COBAS INTEGRA 800, Indianapolis, Indiana, USA). Serum urea, creatinine, Na, K, Uric acid, ALT, AST, ALP and GGT were measured by standard laboratory techniques using an autoanalyzer (Roche Diagnostics, COBAS INTEGRA 800, Indianapolis, Indiana, USA). Complete blood count (CBC) was also recorded for each paticipant before 100-g OGTT. All CBC analysis was performed in the hematology laboratory of our hospital. CBC analysis was performed with the same analyzer within 1 h of collection of blood samples with the use of a Coulter Counter technique (Coulter Gen-S Hematology Analyzer, Beckman Coulter Corp, Hialeah, Florida). Analyses were performed using SPSS 17.0 (SPSS, Inc.,Chicago, Illinois). Values were presented as mean ± standard deviation or, in the case of non-normally distributed data, as median and range. To test the distribution pattern, the Kolmogorov-Smirnov test was used. Categorical variables were summarized as percentages and compared with chi-square test. Spearman correlation coeffi cient was computed to examine the association between 2 continuous variables. Univariate and multivariate logistic regression analysis were performed to identify independent predictors of GDM. Receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off value of NLR with maximum sensitivity and specifi city for development of GDM. Two-tailed P-values of less than 0.05 were considered to indicate statistical signifi cance.
Results
▼
Totally, 110 pregnancy women were included in our study: 42 patients with GDM, 68 patients without GDM (non-GDM). Clinical and biochemical characteristics of both groups are summarized in • ▶ Table 1 . Women with GDM were older, higher parity, and with higher body mass index than non-GDM women (p < 0.001; p < 0.001; p < 0.001, respectively). Patients with GDM also reported History of large birth weight infant and a family history of T2DM more frequently then their healthy counterparts (p < 0.001; p < 0.001, respectively).
The mean NLR values of women with GDM and without GMD were 3.00 ± 0.83 and 2.26 ± 0.43, respectively (P < 0.001) ( • ▶ Fig. 1 ).
The mean FBG, GGT, and Uric acid levels in women with GDM were also signifi cantly higher than those in the non-GDM group Fig. 2 ).
Discussion
▼
In this study, First time we showed that women with GDM have higher NLR to our best knowledge. Elevated levels of NLR is independent predictor for development of GDM. Additionally, our results demonstrate a possible association of subclinical infl ammation with the development of GDM. The link we established between subclinical infl ammation and GDM may be explained through several mechanisms. The precise mechanisms underlying GDM remain unknown. The main hallmark of GDM is increased insulin resistance [ 14 ] . Increased production of placental hormones, especially cortisol, progesterone, human chorionic somatomammotropin (HCS), and to a lesser extent increased fat deposits during pregnancy result in insulin resistance during pregnancy [ 14 , 15 ] . Adipose tissue plays an important role in the regulation of insulin sensitivity by secreting cytokines (leptin, resistin, adiponectin, TNF-α and IL 6.) which are involved in the pathogenesis of pregnancy-induced Downloaded by: University of Washington at Seattle. Copyrighted material. insulin resistance [ 6 ] . This relationship between subclinical infl ammation and insulin resistance has previously been well documented [ 16 ] . Neutrophil lymphocyte ratio (NLR) could be an important measure of systemic infl ammation as it is cost eff ective, readily available and could be calculated easily. NLR has been generally investigated in infl ammatory and neoplastic diseases [ 8 -11 ] . Moreover, recent data also suggests that NLR is prognostic value for in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention [ 9 ] . Buyukkaya E et al. showed that there is a signifi cant correlation between the criteria of Metabolic Syndrome (MS) and infl ammation on the basis of NLR [ 12 ] . We showed fi rst time that NLR is independent predictor for presence of GDM. NLR is powerful subclinical infl ammatory marker. We found that women with GDM have higher levels of GGT than non-GDM. But GGT is not independent predictor for GDM. A raised serum gamma glutamyltransferase (GGT) level is an independent risk factor for type 2 diabetes [ 17 ] . A higher GGT concentration even within its physiological range is a sensitive and early biomarker for the development of diabetes probably mediated through enhanced hepatic neoglucogenesis or early alterations of insülin secretion [ 17 -19 ] . Some studies showed that raised GGT level has been found to be an independent risk factor for GDM [ 18 , 19 ] . However, GGT level has been shown to increase with body mass index and age [ 20 ] . Body mass index also appeared to be more strongly associated with type 2 diabetes when GGT level is above median. In our study, women with GDM were older and heavier and when adjustments were made for these and other signifi cant factors ( • ▶ Table 2 ), GGT was no longer a signifi cant predictive factor for GDM. In our results, higher uric acid would be associated with the development of gestational diabetes. Uric acid is associated with insulin resistance in non-pregnant women [ 21 ] . Outside of pregnancy, hyperuricemia is also associated with the markers of metabolic syndrome, including obesity and dyslipidemia [ 21 ] . Serum uric acid is higher at 24-28 weeks gestation in women diagnosed with gestational diabetes compared to women without diabetes [ 22 ] . Laughon et al. showed that fi rst trimester hyperuricemia is associated with an increased risk of developing GDM, independent of BMI [ 23 ] . Similarly, our fi ndings support assessing uric acid concentration in pregnant women at 24-28 weeks gestation to predict the development of GDM. In our analyses, women with GDM were heavier than non-GDM women. But, prepregnancy BMI was not a signifi cant predictive factor for the development of GDM. Our result could prepregnancy BMI may be as important but not enough an element in the pathophysiology of GDM. We suggested that obesity causes insulin resistance and infl ammation. Although the exact mechanisms involved in the development of GDM are not completely understood, a systemic infl ammation seems to be involved. As adipocytes secrete proinfl ammatory cytokines, infl ammation is generally associated with obesity. Women with GDM have higher body mass index but at the same time increased NLR GDM n = 42 Non-GDM n = 68 P levels and hyperuricemia when adjusments were made for these and other factors, prepergnancy BMI was no signifi cant predictive factor for development of GDM. In addition to these, non-GDM women were usually overweight;In this study, non-GDM group contained a small number of women with normal BMI( < 25 kg/m²). These factors may be confounding variables (NLR, Uric acid). There were some limitations of this study. A cause-eff ect relation could not be established, due to the fact that this was since it was a retrospective analysis. It only reports there is an association between NLR and the developmen of GDM. Second, the levels of infl ammatory cytokines (IL-1, IL-6, TNF-α), chemokines, and chemokine receptors could not be analyzed. In addition to these, since routine fasting insulin levels were not analyzed, therefore HOMA-IR calculations were not performed, and hence insulin resistance was not evaluated. Third, results were dependent on single occasion instead of serial measurements, so laboratory measurement errors aff ect the accuracy of data easily.
In conclusion, In this study we demonstrated for the fi rst time that development of GDM is more common in pregnancy women with a markedly increased NLR level. It will be possible in the future to put the early risk factor of GDM in pregnant women that have no infection with a standardized threshold NLR level if our results are reinforced by future studies. Pregnant women with increased NLR without infection were screened with OGTT to help diagnosing early GDM. Downloaded by: University of Washington at Seattle. Copyrighted material.
